Of America Corp /De/ Bank Sells 412 Shares of HCA Healthcare, Inc. (NYSE:HCA) Stock

HCA Healthcare, Inc. (NYSE:HCA) major shareholder Of America Corp /De/ Bank sold 412 shares of HCA Healthcare stock in a transaction on Tuesday, April 3rd. The shares were sold at an average price of $26.83, for a total transaction of $11,053.96. The sale was disclosed in a document filed with the SEC, which is available through this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

HCA Healthcare Stock Down 0.0 %

HCA stock opened at $342.25 on Friday. The business’s 50-day simple moving average is $324.53 and its 200 day simple moving average is $341.56. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The company has a market cap of $84.26 billion, a PE ratio of 15.58, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the company earned $5.90 earnings per share. On average, research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.84%. The ex-dividend date of this dividend is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is 13.11%.

Institutional Investors Weigh In On HCA Healthcare

Several large investors have recently made changes to their positions in the company. Whipplewood Advisors LLC bought a new position in shares of HCA Healthcare in the fourth quarter valued at approximately $31,000. Tidemark LLC bought a new stake in shares of HCA Healthcare during the fourth quarter worth $36,000. Legacy Investment Solutions LLC bought a new position in shares of HCA Healthcare in the third quarter valued at about $39,000. Activest Wealth Management increased its position in HCA Healthcare by 1,250.0% in the 4th quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after acquiring an additional 125 shares in the last quarter. Finally, Pinnacle Bancorp Inc. grew its stake in shares of HCA Healthcare by 50.0% during the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after purchasing an additional 50 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the company. Morgan Stanley dropped their target price on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th. KeyCorp reduced their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. Truist Financial reduced their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Bank of America cut their target price on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. Finally, Barclays cut their price objective on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.